Chia Tai TianQing Pharmaceutical Group Co., Ltd.
- Biotech or pharma, therapeutic R&D
Seek to out-license a diverse portfolio of over 50 NMEs at preclinical, clinical, and commercial stages. Pipeline spans oncology, metabolic/liver, respiratory, and autoimmune diseases.
CTTQ is one of China’s leading R&D-driven large pharma companies, employing 14,000 people and generating USD $3 billion in total revenue in 2023. It serves as the flagship subsidiary of Sino Biopharmaceutical Ltd. (HKEX: 1177), China’s largest prescription drug company and a member of PharmExec’s Global Top 40 pharma companies.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}